Search Results - "Lebow, Emily S."

Impact of TMB/PD-L1 expression and pneumonitis on chemoradiation and durvalumab response in stage III NSCLC by Alessi, Joao V., Ricciuti, Biagio, Wang, Xinan, Pecci, Federica, Di Federico, Alessandro, Lamberti, Giuseppe, Elkrief, Arielle, Rodig, Scott J., Lebow, Emily S., Eicholz, Jordan E., Thor, Maria, Rimner, Andreas, Schoenfeld, Adam J., Chaft, Jamie E., Johnson, Bruce E., Gomez, Daniel R., Awad, Mark M., Shaverdian, Narek

“…Although concurrent chemoradiation (CRT) and durvalumab consolidation has become a standard treatment for stage III non-small cell lung cancer (NSCLC),…”
Get full text

Multi-institutional analysis of aneuploidy and outcomes to chemoradiation and durvalumab in stage III non-small cell lung cancer by Alessi, Joao V, Price, Adam, Richards, Allison L, Ricciuti, Biagio, Wang, Xinan, Elkrief, Arielle, Pecci, Federica, Di Federico, Alessandro, Gandhi, Malini M, Lebow, Emily S, Santos, Patricia Mae G, Thor, Maria, Rimner, Andreas, Schoenfeld, Adam J, Chaft, Jamie E, Johnson, Bruce E, Gomez, Daniel R, Awad, Mark M, Shaverdian, Narek

“…There is a need to identify predictive biomarkers to guide treatment strategies in stage III non-small cell lung cancer (NSCLCs). In this multi-institutional…”
Get full text

Symptomatic Necrosis With Antibody-Drug Conjugates and Concurrent Stereotactic Radiotherapy for Brain Metastases by Lebow, Emily S, Pike, Luke R G, Seidman, Andrew D, Moss, Nelson, Beal, Kathryn, Yu, Yao

Get more information

Stereotactic body radiation therapy for sarcoma pulmonary metastases by Lebow, Emily S, Lobaugh, Stephanie M, Zhang, Zhigang, Dickson, Mark A, Rosenbaum, Evan, D'Angelo, Sandra P, Nacev, Benjamin A, Shepherd, Annemarie F, Shaverdian, Narek, Wolden, Suzanne, Wu, Abraham J, Gelblum, Daphna Y, Simone, 2nd, Charles B, Gomez, Daniel R, Alektiar, Kaled, Tap, William D, Rimner, Andreas

“…Stereotactic body radiation therapy (SBRT) is standard for patients with inoperable early-stage NSCLC. We hypothesized that SBRT for sarcoma pulmonary…”
Get full text

Characterization of Central Nervous System Clinico-Genomic Outcomes in ALK-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Alectinib by Miao, Emily, Eichholz, Jordan E., Lebow, Emily S., Flynn, Jessica, Zhang, Zhigang, Walch, Henry, Hubbeling, Harper, Beal, Kathryn, Moss, Nelson S., Yu, Kenny K., Meng, Alicia, Kelly, Daniel W., Gomez, Daniel R., Li, Bob T., Rimner, Andreas, Schultz, Nikolaus, Drilon, Alexander, Imber, Brandon S., Pike, Luke R.G.

“…•Extensive series of alectinib-treated lung cancer brain metastases with detailed lesion-level data and genomic correlates.•No differences in clinical outcomes…”
Get full text

Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions by Mondaca, Sebastian, Lebow, Emily S., Namakydoust, Azadeh, Razavi, Pedram, Reis-Filho, Jorge S., Shen, Ronglai, Offin, Michael, Tu, Hai-Yan, Murciano-Goroff, Yonina, Xu, Chongrui, Makhnin, Alex, Martinez, Andres, Pavlakis, Nick, Clarke, Stephen, Itchins, Malinda, Lee, Adrian, Rimner, Andreas, Gomez, Daniel, Rocco, Gaetano, Chaft, Jamie E., Riely, Gregory J., Rudin, Charles M., Jones, David R., Li, Mark, Shaffer, Tristan, Hosseini, Seyed Ali, Bertucci, Caterina, Lim, Lee P., Drilon, Alexander, Berger, Michael F., Benayed, Ryma, Arcila, Maria E., Isbell, James M., Li, Bob T.

“…•Liquid biopsy for plasma ctDNA NGS is capable of partner agnostic detection of ALK fusions.•A subset of patients can be matched to ALK-directed therapy based…”
Get full text

Modelling of late side-effects following cranial proton beam therapy by Dutz, Almut, Lühr, Armin, Agolli, Linda, Bütof, Rebecca, Valentini, Chiara, Troost, Esther G.C., Baumann, Michael, Vermeren, Xavier, Geismar, Dirk, Lamba, Nayan, Lebow, Emily S., Bussière, Meghan, Daly, Jillian E., Bussière, Marc R., Krause, Mechthild, Timmermann, Beate, Shih, Helen A., Löck, Steffen

“…•Availability of proton therapy is limited requiring individual treatment selection strategies.•Selection strategies may be based on NTCP models, some of which…”
Get full text

Early experience with hippocampal avoidance whole brain radiation therapy and simultaneous integrated boost for brain metastases by Lebow, Emily S., Hwang, William L., Zieminski, Stephen, Wang, Yi, Niemierko, Andrzej, Mehan, William A., Oh, Kevin S., Khandekar, Melin, Willers, Henning, Shih, Helen A.

“…Purpose Cranial irradiation results in cognitive decline, which is hypothesized to be partially attributable to hippocampal injury and stem cell loss. Recent…”
Get full text

Proton therapy for head and neck paragangliomas: A single institutional experience by Kang, Kylie H., Lebow, Emily S., Niemierko, Andrzej, Bussière, Marc R., Dewyer, Nicholas A., Daly, Jillian, McKenna, Michael J., Lee, Daniel J., Loeffler, Jay S., Busse, Paul M., Shih, Helen A.

“…Background Although slow growing, head and neck paragangliomas (HNPG) can cause significant morbidity. We evaluated the efficacy of proton therapy in the…”
Get full text

Corrigendum to “Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions” [Lung Cancer 159 (2021) 66–73] by Mondaca, Sebastian, Lebow, Emily S., Namakydoust, Azadeh, Razavi, Pedram, Reis-Filho, Jorge S., Shen, Ronglai, Offin, Michael, Tu, Hai-Yan, Murciano-Goroff, Yonina, Xu, Chongrui, Makhnin, Alex, Martinez, Andres, Pavlakis, Nick, Clarke, Stephen, Itchins, Malinda, Lee, Adrian, Rimner, Andreas, Gomez, Daniel, Rocco, Gaetano, Chaft, Jamie E., Riely, Gregory J., Rudin, Charles M., Jones, David R., Li, Mark, Shaffer, Tristan, Hosseini, Seyed Ali, Bertucci, Caterina, Lim, Lee P., Drilon, Alexander, Berger, Michael F., Benayed, Ryma, Arcila, Maria E., Isbell, James M., Li, Bob T.

Get full text

Radiation Therapy for IDH-Mutant Grade 2 and Grade 3 Diffuse Glioma: An ASTRO Clinical Practice Guideline by Halasz, Lia M., Attia, Albert, Bradfield, Lisa, Brat, Daniel J., Kirkpatrick, John P., Laack, Nadia N., Lalani, Nafisha, Lebow, Emily S., Liu, Arthur K., Niemeier, Heather M., Palmer, Joshua D., Peters, Katherine B., Sheehan, Jason, Thomas, Reena P., Vora, Sujay A., Wahl, Daniel R., Weiss, Stephanie E., Yeboa, D. Nana, Zhong, Jim, Shih, Helen A.

“…This guideline provides evidence-based recommendations for adults with isocitrate dehydrogenase (IDH)–mutant grade 2 and grade 3 diffuse glioma, as classified…”
Get full text

ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy by Lebow, Emily S, Shaverdian, Narek, Eichholz, Jordan E, Kratochvil, Leah B, McCune, Megan, Murciano-Goroff, Yonina R, Jee, Justin, Eng, Juliana, Chaft, Jamie E, Kris, Mark G, Kalashnikova, Ekaterina, Feeney, Jordan, Scalise, Carly Bess, Sudhaman, Sumedha, Palsuledesai, Charuta C, Malhotra, Meenakshi, Krainock, Michael, Sethi, Himanshu, Aleshin, Alexey, Liu, Minetta C, Shepherd, Annemarie F, Wu, Abraham J, Simone, 2nd, Charles B, Gelblum, Daphna Y, Johnson, Kaylie A, Rudin, Charles M, Gomez, Daniel R, Razavi, Pedram, Reis-Filho, Jorge S, Isbell, James M, Li, Bob T, Rimner, Andreas

“…Sensitive and reliable biomarkers for early detection of recurrence are needed to improve post-definitive radiation risk stratification, disease management,…”
Get full text

Tumor volume as a predictor of cell free DNA mutation detection in advanced non-small cell lung cancer by Haseltine, Justin M., Offin, Michael, Flynn, Jessica R., Zhang, Zhigang, Lebow, Emily S., Aziz, Khaled, Makhnin, Alex, Eichholz, Jordan, Lim, Lee P., Li, Mark, Isbell, James M., Gomez, Daniel R., Li, Bob T., Rimner, Andreas

Get full text

Analysis of Tumor Mutational Burden, Progression-Free Survival, and Local-Regional Control in Patents with Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation and Durvalumab by Lebow, Emily S, Shepherd, Annemarie, Eichholz, Jordan E, Offin, Michael, Gelblum, Daphna Y, Wu, Abraham J, Simone, 2nd, Charles B, Schoenfeld, Adam J, Jones, David R, Rimner, Andreas, Chaft, Jamie E, Riaz, Nadeem, Gomez, Daniel R, Shaverdian, Narek

“…The addition of consolidative durvalumab to chemoradiation has improved disease control and survival in locally advanced non-small cell lung cancer (NSCLC)…”
Get full text

Analysis of Tumor Mutational Burden, Progression-Free Survival, and Local-Regional Control in Patients with Locally Advanced Non–Small Cell Lung Cancer Treated With Chemoradiation and Durvalumab by Lebow, Emily S., Shepherd, Annemarie, Eichholz, Jordan E., Offin, Michael, Gelblum, Daphna Y., Wu, Abraham J., Simone, Charles B., Schoenfeld, Adam J., Jones, David R., Rimner, Andreas, Chaft, Jamie E., Riaz, Nadeem, Gomez, Daniel R., Shaverdian, Narek

“…Importance The addition of consolidative durvalumab to chemoradiation has improved disease control and survival in locally advanced non–small cell lung cancer…”
Get full text

Early Circulating Tumor DNA Shedding Kinetics for Prediction of Platinum Sensitivity in Patients With Small Cell Lung Cancer by Murciano-Goroff, Yonina R, Hui, Angela B-Y, Araujo Filho, Jose A, Hamilton, Emily G, Chabon, Jacob J, Moding, Everett J, Bonilla, Rene F, Lebow, Emily S, Gomez, Daniel, Rimner, Andreas, Ginsberg, Michelle S, Offin, Michael, Kundra, Ritika, Allaj, Viola, Norton, Larry, Reis-Filho, Jorge S, Razavi, Pedram, Drilon, Alexander, Jones, David R, Isbell, James M, Lai, W Victoria, Rudin, Charles M, Alizadeh, Ash A, Li, Bob T, Diehn, Maximilian

“…Small cell lung cancer (SCLC) is characterized by rapid progression after platinum resistance. Circulating tumor (ctDNA) dynamics early in treatment may help…”
Get more information

"Big Boom" (4 Gy x 1) Radiation Treatment (RT) Versus "Big Boom" (2 Gy x 2) for Non-Hodgkin Lymphoma (NHL) by Hajj, Carla, Lebow, Emily S., Lee, Jisun, Fregonese, Beatrice, Wijetunga, N. Ari, Hubbeling, Harper, Tringale, Kathryn R., Freret, Morgan E., Imber, Brandon S., Yahalom, Joachim

Get full text

Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer by Jee, Justin, Lebow, Emily S., Yeh, Randy, Das, Jeeban P., Namakydoust, Azadeh, Paik, Paul K., Chaft, Jamie E., Jayakumaran, Gowtham, Rose Brannon, A., Benayed, Ryma, Zehir, Ahmet, Donoghue, Mark, Schultz, Nikolaus, Chakravarty, Debyani, Kundra, Ritika, Madupuri, Ramyasree, Murciano-Goroff, Yonina R., Tu, Hai-Yan, Xu, Chong-Rui, Martinez, Andrés, Wilhelm, Clare, Galle, Jesse, Daly, Bobby, Yu, Helena A., Offin, Michael, Hellmann, Matthew D., Lito, Piro, Arbour, Kathryn C., Zauderer, Marjorie G., Kris, Mark G., Ng, Kenneth K., Eng, Juliana, Preeshagul, Isabel, Victoria Lai, W., Fiore, John J., Iqbal, Afsheen, Molena, Daniela, Rocco, Gaetano, Park, Bernard J., Lim, Lee P., Li, Mark, Tong-Li, Candace, De Silva, Madhawa, Chan, David L., Diakos, Connie I., Itchins, Malinda, Clarke, Stephen, Pavlakis, Nick, Lee, Adrian, Rekhtman, Natasha, Chang, Jason, Travis, William D., Riely, Gregory J., Solit, David B., Gonen, Mithat, Rusch, Valerie W., Rimner, Andreas, Gomez, Daniel, Drilon, Alexander, Scher, Howard I., Shah, Sohrab P., Berger, Michael F., Arcila, Maria E., Ladanyi, Marc, Levine, Ross L., Shen, Ronglai, Razavi, Pedram, Reis-Filho, Jorge S., Jones, David R., Rudin, Charles M., Isbell, James M., Li, Bob T.

“…Circulating tumor DNA (ctDNA) sequencing guides therapy decisions but has been studied mostly in small cohorts without sufficient follow-up to determine its…”
Get full text

Primary Hepatic Lymphoma: Role of Low-Dose Radiotherapy at a Single Institution with Genetic Characterization and Paired Literature Review by Ma, Jennifer, Daou, Remy, Bou Eid, Josiane, Lee, Jisun, Fregonese, Beatrice, El-Khoury, Joe, Wijetunga, Neil Ari, Hubbeling, Harper, Tringale, Kathryn R., Lebow, Emily S., Sarkar, Reith, Imber, Brandon S., Yahalom, Joachim, Hajj, Carla

Get full text

Genetic Alterations of Crebbp Are Associated with Radiosensitivity in Follicular Lymphoma by Wijetunga, Neil Ari, Lebow, Emily S., Lee, Jisun, Fregonese, Beatrice, Tringale, Kathryn R., Hubbeling, Harper, Sarkar, Reith, Ma, Jennifer, Seshan, Venkatraman, Joffe, Erel, Dogan, Ahmet, Chan, Alexander, Wendel, Guido, Hajj, Carla, Imber, Brandon S., Yahalom, Joachim

Get full text